Thc Biomed Intl Stock Probability Of Bankruptcy

THCBF Stock  USD 0.02  0.0001  0.62%   
THC Biomed's odds of distress is under 17% at the present time. It has tiny probability of undergoing some form of financial crunch in the near future. THC Biomed's Chance of financial distress is determined by interpolating and adjusting THC Altman Z Score to account for off-balance-sheet items and missing or unfiled public information. All items used in analyzing the odds of distress are taken from the THC balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in THC Biomed Intl. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
  

THC Biomed Intl Company chance of financial distress Analysis

THC Biomed's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Probability Of Bankruptcy

 = 

Normalized

Z-Score

More About Probability Of Bankruptcy | All Equity Analysis

Current THC Biomed Probability Of Bankruptcy

    
  Less than 17%  
Most of THC Biomed's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, THC Biomed Intl is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of THC Biomed probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting THC Biomed odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of THC Biomed Intl financial health.
Please note, there is a significant difference between THC Biomed's value and its price as these two are different measures arrived at by different means. Investors typically determine if THC Biomed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, THC Biomed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
Competition

Based on the latest financial disclosure, THC Biomed Intl has a Probability Of Bankruptcy of 17.0%. This is 60.73% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The probability of bankruptcy for all United States stocks is 57.32% higher than that of the company.

THC Probability Of Bankruptcy Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses THC Biomed's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of THC Biomed could also be used in its relative valuation, which is a method of valuing THC Biomed by comparing valuation metrics of similar companies.
THC Biomed is currently under evaluation in probability of bankruptcy category among related companies.

THC Fundamentals

About THC Biomed Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze THC Biomed Intl's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of THC Biomed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of THC Biomed Intl based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in THC Biomed Intl. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Note that the THC Biomed Intl information on this page should be used as a complementary analysis to other THC Biomed's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for THC Pink Sheet analysis

When running THC Biomed's price analysis, check to measure THC Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy THC Biomed is operating at the current time. Most of THC Biomed's value examination focuses on studying past and present price action to predict the probability of THC Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move THC Biomed's price. Additionally, you may evaluate how the addition of THC Biomed to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Global Correlations
Find global opportunities by holding instruments from different markets
Please note, there is a significant difference between THC Biomed's value and its price as these two are different measures arrived at by different means. Investors typically determine if THC Biomed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, THC Biomed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.